Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study

References

• WeeJTHaTCLoongSLQianCNIs nasopharyngeal cancer really a “Cantonese cancer”?Chin J Cancer201029551752620426903
   PubMedGoogle Scholar
• PengGWangTYangKYA prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinomaRadiother Oncol2012104328629322995588
   PubMed Web of Science ®Google Scholar
• ZhangMXLiJShenGPIntensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-upEur J Cancer201551172587259526318726
   PubMed Web of Science ®Google Scholar
• KwongDLShamJSAuGKConcurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial studyJ Clin Oncol200422132643265315226332
   PubMed Web of Science ®Google Scholar
• WuXHuangPYPengPJLong-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinomaAnn Oncol20132482131213623661293
   PubMed Web of Science ®Google Scholar
• ChanATLeungSFNganRKOverall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinomaJ Natl Cancer Inst200597753653915812080
   PubMed Web of Science ®Google Scholar
• LinJCJanJSHsuCYLiangWMJiangRSWangWYPhase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survivalJ Clin Oncol200321463163712586799
   PubMed Web of Science ®Google Scholar
• ChenYSunYLiangSBProgress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of ChinaCancer2013119122230223823576020
   PubMed Web of Science ®Google Scholar
• LeeAWTungSYChuaDTRandomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinomaJ Natl Cancer Inst2010102151188119820634482
   PubMed Web of Science ®Google Scholar
• WeeJTanEHTaiBCRandomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varietyJ Clin Oncol200523276730673816170180
   PubMed Web of Science ®Google Scholar
• TanTLimWTFongKWConcurrent chemo-radiation with or without induction gemcitabine, Carboplatin, and Paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal carcinomaInt J Radiat Oncol Biol Phys201591595296025832687
   PubMed Web of Science ®Google Scholar
• FountzilasGCiuleanuEBobosMInduction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationAnn Oncol201223242743521525406
   PubMed Web of Science ®Google Scholar
• SunYLiWFChenNYInduction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trialLancet Oncol201617111509152027686945
   PubMed Web of Science ®Google Scholar
• HuiEPMaBBLeungSFRandomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinomaJ Clin Oncol200927224224919064973
   PubMed Web of Science ®Google Scholar
• LanXWZouXBXiaoYRetrospective analysis of the survival benefit of induction chemotherapy in stage IVa-b nasopharyngeal carcinomaPLoS One2016118e160758
   Google Scholar
• D’AgostinoRJPropensity score methods for bias reduction in the comparison of a treatment to a non-randomized control groupStat Med19981719226522819802183
   PubMed Web of Science ®Google Scholar
• AustinPCThe use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experimentsStat Med20143371242125824122911
   PubMed Web of Science ®Google Scholar
• ShaoJYZhangYLiYHComparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinomaAnticancer Res20042464059406615736452
   PubMed Web of Science ®Google Scholar
• LoYMChanLYLoKWQuantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinomaCancer Res19995961188119110096545
   PubMedGoogle Scholar
• EdgeSBComptonCCThe American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNMAnn Surg Oncol20101761471147420180029
   PubMed Web of Science ®Google Scholar
• LeungSFZeeBMaBBPlasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinomaJ Clin Oncol200624345414541817135642
   PubMed Web of Science ®Google Scholar
• OuyangPYSuZMaoYPPrognostic impact of cigarette smoking on the survival of patients with established nasopharyngeal carcinomaCancer Epidemiol Biomarkers Prev201322122285229424252872
   PubMedGoogle Scholar
• GuoSSHuangPYChenQYThe impact of smoking on the clinical outcome of locoregionally advanced nasopharyngeal carcinoma after chemoradiotherapyRadiat Oncol2014924625424191
   PubMedGoogle Scholar
• OuyangPYSuZMaoYPLiangXXLiuQXieFYPrognostic impact of family history in southern Chinese patients with undifferentiated nasopharyngeal carcinomaBr J Cancer2013109378879423807164
   PubMedGoogle Scholar
• AnXWangFHDingPRPlasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapyCancer2011117163750375721319149
   PubMed Web of Science ®Google Scholar
• PengHGuoRChenLPrognostic impact of plasma Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma treated using intensity-modulated radiation therapySci Rep201662200026924234
   PubMed Web of Science ®Google Scholar
• LinJCWangWYChenKYQuantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinomaN Engl J Med2004350242461247015190138
   PubMed Web of Science ®Google Scholar
• LeungSFChanATZeeBPretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated typeCancer200398228829112872347
   PubMed Web of Science ®Google Scholar
• LinJCLiangWMJanJSJiangRSLinACAnother way to estimate outcome of advanced nasopharyngeal carcinoma–is concurrent chemoradiotherapy adequate?Int J Radiat Oncol Biol Phys200460115616415337551
   PubMedGoogle Scholar
• LeeAWLauWHTungSYPreliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study GroupJ Clin Oncol200523286966697516192584
   PubMed Web of Science ®Google Scholar
• ChenLLiuLZChenMPrognostic value of subclassification using MRI in the t4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatmentInt J Radiat Oncol Biol Phys201284119620222300569
   PubMedGoogle Scholar
• XuTZhuGHeXYingHHuCA phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomesOral Oncol2014502717624315404
   PubMedGoogle Scholar
• PengHChenLZhangYSurvival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus statusOncotarget2016717242082421627008701
   PubMedGoogle Scholar
• WanXBWeiLLiHHigh pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinomaEur J Cancer201349102356236423541571
   PubMed Web of Science ®Google Scholar
• ZhouGQRenXYMaoYPPrognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapySci Rep201662232626928265
   PubMed Web of Science ®Google Scholar